Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mainz Biomed (MYNZ) Prepaid Assets (2020 - 2025)

Mainz Biomed's Prepaid Assets history spans 3 years, with the latest figure at $1.2 million for Q4 2023.

  • For Q4 2023, Prepaid Assets changed N/A year-over-year to $1.2 million; the TTM value through Dec 2023 reached $1.2 million, changed N/A, while the annual FY2023 figure was $1.2 million, N/A changed from the prior year.
  • Prepaid Assets for Q4 2023 was $1.2 million at Mainz Biomed, up from $863910.0 in the prior quarter.
  • Across five years, Prepaid Assets topped out at $1.2 million in Q4 2023 and bottomed at $19589.0 in Q4 2020.
  • The 3-year median for Prepaid Assets is $863910.0 (2021), against an average of $695056.3.
  • The largest YoY upside for Prepaid Assets was 4310.18% in 2021 against a maximum downside of 4310.18% in 2021.
  • A 3-year view of Prepaid Assets shows it stood at $19589.0 in 2020, then skyrocketed by 4310.18% to $863910.0 in 2021, then skyrocketed by 39.1% to $1.2 million in 2023.
  • Per Business Quant, the three most recent readings for MYNZ's Prepaid Assets are $1.2 million (Q4 2023), $863910.0 (Q4 2021), and $19589.0 (Q4 2020).